Quantcast
Last updated on April 19, 2014 at 1:20 EDT

Latest Plasma cell leukemia Stories

2013-08-20 08:31:08

STOCKHOLM, August 20, 2013 /PRNewswire/ -- Oncopeptides AB, a company working to enhance oncology therapies, today announced that the first patient has been dosed as part of a Phase II study in multiple myeloma patients with its drug candidate melflufen (previously called J1). (Logo: http://photos.prnewswire.com/prnh/20130521/613959 ) The trial is an open-label Phase II study designed to determine the level of efficacy of melflufen in combination with...

2012-06-04 02:24:12

WASHINGTON, June 4, 2012 /PRNewswire-USNewswire/ -- Results from a study published online today in Blood, the Journal of the American Society of Hematology (ASH), demonstrate that inclusion of carfilzomib, a novel targeted therapy for multiple myeloma, in combination with lenalidomide and low-dose dexamethasone, resulted in complete or near complete remission in a majority of patients with newly diagnosed multiple myeloma. Multiple myeloma is cancer of the plasma cells, the white blood cells...

2009-12-18 09:47:00

HACKENSACK, N.J., Dec. 18 /PRNewswire/ -- Doctors and researchers from the John Theurer Cancer Center at Hackensack University Medical Center recently presented research updates and clinical trial results of more than 20 innovative studies at the American Society of Hematology (ASH) annual meeting from December 5-8, 2009. Their research involved some of the most promising cancer-treatment candidates in the pipeline today, including Carfilzomib and Difibrotide; two therapies offering...

2009-02-10 07:00:00

Scientists at the Institute for Myeloma and Bone Cancer Research (IMBCR) have uncovered a new pathway that could explain how blood vessels form within tumors. LOS ANGELES, Feb. 10 /PRNewswire-USNewswire/ -- IMBCR researchers uncovered a new way that cancers orchestrate the production of their own blood supply. Recent studies have shown that many tumors make a protein called pleiotrophin (PTN). They now show that PTN produced by tumor cells in multiple myeloma, a common form of bone...

2007-12-22 03:00:08

By Bahat, Gulistan Erten, Nilgun; Saka, Bulent; Uzun, Sami; Onur, Imran; Kalayoglu-Besisik, Sevgi; Buyukbabani, Nesimi Keywords: IgD lambda myeloma, AL amyloidosis, amyloid arthropathy, mucocutaneous amyloidosis Abbreviations: MM = multiple myeloma; IgD = immunoglobulin D Abstract Multiple myeloma (MM) is associated with amyloidosis in approximately 15% of the patients. The most frequent presenting signs of such an association are nephrotic syndrome, cardiomyopathy and peripheral...

2005-06-20 16:50:00

When people hear "thalidomide," many think "birth defects," however, evidence has come to light that this once-banned drug can be used as a potent anti-cancer treatment. In a new study, researchers from the University of Bologna, Italy, demonstrate that Thal-Dex (thalidomide used in combination with dexamethasone) is more powerful than conventional chemotherapy for the treatment of multiple myeloma. Their findings will be published in the July 1, 2005, issue of Blood, the official journal of...